Successful use of cannabidiol in nonconvulsive status epilepticus in Angelman syndrome

Epilepsia Open. 2024 Oct;9(5):1997-1999. doi: 10.1002/epi4.12948. Epub 2024 Aug 22.

Authors

Nicola Pietrafusa¹, Luca De Palma¹, Michelina Armando², Tiziana Corsetti³, Federico Vigevano⁴, Nicola Specchio¹

Affiliations

¹ Neurology, Epilepsy and Movement Disorders Unit, Full Member of European Reference Network EpiCARE, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
² Department of Neurorehabilitation, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
³ Hospital Pharmacy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
⁴ Neurological Sciences and Rehabilitation Medicine Scientific Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Angelman Syndrome* / drug therapy
Anticonvulsants / therapeutic use
Cannabidiol* / therapeutic use
Child
Female
Humans
Male
Status Epilepticus* / drug therapy
Treatment Outcome

Substances

Cannabidiol
Anticonvulsants